We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Silver Linings

Silver Linings

We anticipate taking learnings and new ways of working, developed out of critical need, into the post-pandemic world — from engaging in partnerships and advancing clinical trials to leveraging virtual technology.